title: VWD type 2N (Normandy) in two sisters.
authors: Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, USA.
authors: J L
authors: JL
authors: Agne
authors: Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
authors: N
authors: N
authors: Ahmad
authors: Division of Hematology and Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
authors: J E
authors: JE
authors: Palascak
authors: Division of Hematology and Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
authors: R
authors: R
authors: Khaled
authors: Division of Hematology and Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
authors: N A
authors: NA
authors: Karim
mesh_terms: D000328:Adult; D001780:Blood Coagulation Tests; D004909:Erythrocyte Indices; D005169:Factor VIII / Q000378:metabolism; D005260:Female; D006406:Hematoma / Q000209:etiology; D006801:Humans; D035781:Siblings; D055815:Young Adult; D056728:von Willebrand Disease, Type 2 / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D014841:von Willebrand Factor / Q000737:chemistry / Q000378:metabolism
chemical_list: D014841:von Willebrand Factor; D005169:Factor VIII
references: Philipp CS, Faiz A, Dowling N et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 2005; 105: 61-6.
references: Palareti G, Leali N, Coccheri S et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-8.
references: Rodeghiero R, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454-9.
references: Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-9.
references: Gaucher C, Jorieux S, Mercier B, Oufkir D, Mazurier C. The, “Normandy” variant of von Willebrand disease: characterization of a point mutation in the von Willebrand factor gene. Blood 1991; 77: 1937-41.
references: Michiels J, Berneman Z, Gadisseur A et al. Classification and characterization of hereditary Types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease. Clin Appl Thromb Hemost 2006; 12: 397-420.
references: Michiels J, van de Velde A, van Vliet H, van der Planken M, Schroyens W, Berneman Z. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications. Semin Thromb Hemost 2002; 28: 111.
references: Michiels J, van Vliet H, Berneman Z et al. Intravenous DDAVP and Factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients with von Willebrand disease type 1, 2 and 3. Clin Appl Thromb Hemost 2007; 13: 14-34.
references: Michiels J, Berneman Z, Planken M, Schroyens W, Budde U, Vliet H. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII - von Willebrand factor concentrate (Haemate-P). Blood Coagul Fibrinolysis 2004; 15: 323-30.
references: Castaman G, Bertoncello K, Bernardi M, Rodeghiero F. Pregnancy and delivery in patients with homozygous and heterozygous R854Q type 2N von Willebrand disease. J Thromb Haemost 2005; 3: 391-2.